GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Myrexis Inc (OTCPK:MYRX) » Definitions » Market Cap
中文

Myrexis (Myrexis) Market Cap : $0.36 Mil (As of Apr. 24, 2024)


View and export this data going back to 2013. Start your Free Trial

Myrexis (Myrexis) Definition

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Myrexis's share price for the quarter that ended in Jun. 2013 was $0.075. Myrexis's Shares Outstanding (EOP) for the quarter that ended in Jun. 2013 was 34.48 Mil. Therefore, Myrexis's market cap for the quarter that ended in Jun. 2013 was $2.59 Mil.

Myrexis's quarterly market cap declined from Dec. 2012 ($76.96 Mil) to Mar. 2013 ($3.45 Mil) and declined from Mar. 2013 ($3.45 Mil) to Jun. 2013 ($2.59 Mil).

Myrexis's annual market cap declined from Jun. 2011 ($93.27 Mil) to Jun. 2012 ($69.93 Mil) and declined from Jun. 2012 ($69.93 Mil) to Jun. 2013 ($2.59 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Myrexis's Enterprise Value for Today is $0.36 Mil.


Myrexis Market Cap Historical Data

The historical data trend for Myrexis's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Myrexis Annual Data
Trend Jun08 Jun09 Jun10 Jun11 Jun12 Jun13
Market Cap
Get a 7-Day Free Trial 111.48 94.80 93.27 69.93 2.59

Myrexis Quarterly Data
Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 69.93 65.17 76.96 3.45 2.59

Competitive Comparison

For the Shell Companies subindustry, Myrexis's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Myrexis Market Cap Distribution

For the Diversified Financial Services industry and Financial Services sector, Myrexis's Market Cap distribution charts can be found below:

* The bar in red indicates where Myrexis's Market Cap falls into.



Myrexis Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Myrexis's Market Cap for the fiscal year that ended in Jun. 2013 is calculated as

Market Cap (A: Jun. 2013 )=Share Price (A: Jun. 2013 )*Shares Outstanding (EOP) (A: Jun. 2013 )
=$0.075*34.479
=$2.59

Myrexis's Market Cap for the quarter that ended in Jun. 2013 is calculated as

Market Cap (Q: Jun. 2013 )=Share Price (Q: Jun. 2013 )*Shares Outstanding (EOP) (Q: Jun. 2013 )
=$0.075*34.479
=$2.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Myrexis  (OTCPK:MYRX) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Myrexis Market Cap Related Terms

Thank you for viewing the detailed overview of Myrexis's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Myrexis (Myrexis) Business Description

Traded in Other Exchanges
N/A
Address
630 Fifth Avenue, Suite 2260, New York, NY, USA, 10020
Myrexis Inc is engaged in evaluating strategic alternatives, such as identifying, evaluating and making financial investments in life sciences assets.
Executives
Xstelos Corp. 10 percent owner 630 FIFTH AVENUE, SUITE 2260, NEW YORK NY 10020
Steven D Scheiwe director 1741 EDGEFIELD LANE, ENCINITAS CA 92024
Pearce Michael Cooper director 213 RHODODENDRON DRIVE, CHAPEL HILL NC 27517
Jonathan Couchman director, officer: Chairman, President and CEO 630 FIFTH AVENUE, SUITE 2260, NEW YORK NY 10020
John T Henderson director 320 WAKARA WAY, SALT LAKE CITY UT 84108
First Eagle Investment Management, Llc 10 percent owner 1345 AVENUE OF THE AMERICAS, NEW YORK NY 10105
Jason Aryeh director 11119 NORTH TORREY PINES ROAD, SUITE 200, LA JOLLA CA 92037
Gerald P. Belle director 320 WAKARA WAY, SALT LAKE CITY UT 84108
David W Gryska director, officer: Chief Operating Officer 749 N MARY AVE, SUNNYVALE CA 94085
Richard B Brewer director, officer: President and CEO C/O DENDREON CORP, 3005 1ST AVE, SEATTLE WA 98121
Timothy R Franson director 320 WAKARA WAY, SALT LAKE CITY UT 84108
Dennis Langer director C/O PETER TSOFLIAS, BLANK ROME LLP, ONE LOGAN SQUARE, FL 9, PHILADELPHA PA 19103
Robert Forrester director C/O COMBINATORX, INCORPORATED, 245 FIRST STREET, 3RD FLOOR, CAMBRIDGE MA 02142
Adrian N Hobden director, officer: President and CEO 320 WAKARA WAY, SALT LAKE CITY UT 84108
W Wayne Laslie officer: Chief Operating Officer 320 WAKARA WAY, SALT LAKE CITY UT 84108

Myrexis (Myrexis) Headlines